Healthcare provider profile · identity verified

Kendall S Bos, MD

Internal Medicine · WILLMAR, MN · NPI 1427024561

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	357	89
Omeprazole	Omeprazole	349	81
Levothyroxine Sodium	Levothyroxine Sodium	316	70
Losartan Potassium	Losartan Potassium	311	76
Gabapentin	Gabapentin	298	68
Amlodipine Besylate	Amlodipine Besylate	292	78
Furosemide	Furosemide	276	66
Lisinopril	Lisinopril	248	70
Metoprolol Succinate	Metoprolol Succinate	237	54
Metformin Hcl Er	Metformin Hcl	222	48
Spironolactone	Spironolactone	205	41
Rosuvastatin Calcium	Rosuvastatin Calcium	193	51
Eliquis	Apixaban	181	37
Simvastatin	Simvastatin	180	42
Allopurinol	Allopurinol	156	39
Sertraline Hcl	Sertraline Hcl	140	28
Warfarin Sodium	Warfarin Sodium	138	29
Carvedilol	Carvedilol	133	33
Tamsulosin Hcl	Tamsulosin Hcl	124	33
Jantoven	Warfarin Sodium	119	13
Hydrochlorothiazide	Hydrochlorothiazide	93	33
Fluoxetine Hcl	Fluoxetine Hcl	91	14
Labetalol Hcl	Labetalol Hcl	88	19
Metoprolol Tartrate	Metoprolol Tartrate	87	28
Fluticasone Propionate	Fluticasone Propionate	80	24
Torsemide	Torsemide	80	14
Quetiapine Fumarate	Quetiapine Fumarate	79	suppressed
Pantoprazole Sodium	Pantoprazole Sodium	77	22
Mirtazapine	Mirtazapine	74	17
Potassium Chloride	Potassium Chloride	74	23
Pravastatin Sodium	Pravastatin Sodium	74	19
Donepezil Hcl	Donepezil Hcl	71	11
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	64	13
Famotidine	Famotidine	64	21
Celecoxib	Celecoxib	60	18
Metformin Hcl	Metformin Hcl	60	18
Prednisone	Prednisone	59	37
Trazodone Hcl	Trazodone Hcl	57	15
Irbesartan	Irbesartan	56	15
Montelukast Sodium	Montelukast Sodium	55	16
Glipizide	Glipizide	53	suppressed
Klor-Con M20	Potassium Chloride	50	suppressed
Spironolactone-Hctz	Spironolact/Hydrochlorothiazid	50	suppressed
Duloxetine Hcl	Duloxetine Hcl	47	13
Atenolol	Atenolol	46	14
Citalopram Hbr	Citalopram Hydrobromide	46	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	46	13
Clopidogrel	Clopidogrel Bisulfate	44	13
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	44	11
Isosorbide Mononitrate Er	Isosorbide Mononitrate	43	12
Venlafaxine Hcl Er	Venlafaxine Hcl	43	suppressed
Paroxetine Hcl	Paroxetine Hcl	41	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	41	suppressed
Clonidine Hcl	Clonidine Hcl	40	suppressed
Hydralazine Hcl	Hydralazine Hcl	40	suppressed
Pregabalin	Pregabalin	40	12
Lovastatin	Lovastatin	38	suppressed
Cephalexin	Cephalexin	37	20
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	36	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	33	suppressed
Metoclopramide Hcl	Metoclopramide Hcl	30	suppressed
Enalapril Maleate	Enalapril Maleate	29	suppressed
Latanoprost	Latanoprost	29	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	29	suppressed
Ropinirole Hcl	Ropinirole Hcl	29	suppressed
Terazosin Hcl	Terazosin Hcl	29	suppressed
Trospium Chloride	Trospium Chloride	29	suppressed
Fludrocortisone Acetate	Fludrocortisone Acetate	28	suppressed
Albuterol Sulfate Hfa	Albuterol Sulfate	27	13
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	27	suppressed
Chlorthalidone	Chlorthalidone	26	suppressed
Levetiracetam	Levetiracetam	26	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	25	suppressed
Risperidone	Risperidone	25	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	24	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	23	suppressed
Synthroid	Levothyroxine Sodium	23	suppressed
Ventolin Hfa	Albuterol Sulfate	23	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	22	18
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	21	18
Armodafinil	Armodafinil	21	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	21	suppressed
Amoxicillin	Amoxicillin	20	18
Azelastine Hcl	Azelastine Hcl	20	suppressed
Dulera	Mometasone/Formoterol	20	suppressed
Tramadol Hcl	Tramadol Hcl	20	11
Ursodiol	Ursodiol	20	suppressed
Verapamil Er	Verapamil Hcl	20	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	19	suppressed
Nifedipine Er	Nifedipine	19	suppressed
Ozempic	Semaglutide	19	suppressed
Methocarbamol	Methocarbamol	18	suppressed
Xarelto	Rivaroxaban	18	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	17	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	17	15
Nystatin	Nystatin	17	12
Azithromycin	Azithromycin	16	15
Divalproex Sodium Er	Divalproex Sodium	16	suppressed
Finasteride	Finasteride	16	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	16	suppressed
Albuterol Sulfate	Albuterol Sulfate	15	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	15	suppressed
Breo Ellipta	Fluticasone/Vilanterol	15	suppressed
Bupropion Xl	Bupropion Hcl	15	suppressed
Ezetimibe	Ezetimibe	15	suppressed
Hydrocortisone	Hydrocortisone	15	suppressed
Hydroxychloroquine Sulfate	Hydroxychloroquine Sulfate	15	suppressed
Loperamide	Loperamide Hcl	15	suppressed
Propranolol Hcl	Propranolol Hcl	15	suppressed
Sucralfate	Sucralfate	15	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	14	12
Dutasteride	Dutasteride	14	suppressed
Fiasp Flextouch	Insulin Aspart (Niacinamide)	14	suppressed
Glipizide Er	Glipizide	14	suppressed
Creon	Lipase/Protease/Amylase	13	suppressed
Jardiance	Empagliflozin	13	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	13	suppressed
Topiramate	Topiramate	13	suppressed
Doxepin Hcl	Doxepin Hcl	12	suppressed
Januvia	Sitagliptin Phosphate	12	suppressed
Bumetanide	Bumetanide	11	suppressed
Clonazepam	Clonazepam	11	suppressed
Flecainide Acetate	Flecainide Acetate	11	suppressed
Irbesartan-Hydrochlorothiazide	Irbesartan/Hydrochlorothiazide	11	suppressed
Oxycodone Hcl	Oxycodone Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error